Laxminarayan Bhat, PhD

home / authors / laxminarayan-bhat-phd

Dr Bhat is founder, president, and chief executive officer of

Reviva Pharmaceuticals Holdings Inc.

Articles

Open Label Phase 3 Study of Brilaroxazine for Schizophrenia Shows Efficacy, Tolerability

Open Label Phase 3 Study of Brilaroxazine for Schizophrenia Shows Efficacy, Tolerability

Laxminarayan Bhat, PhD;Heidi Anne Duerr, MPH

The RECOVER open label trial demonstrated positive results for brilaroxazine for schizophrenia.

Latest Updated Articles

Mini Quiz: Treatment for Pedophilia?

Published: March 19th 2021 | Updated: June 5th 2025

Mini Quiz: Treatment for Pedophilia?

Mini Quiz: Assessment of Malingering

Published: April 1st 2019 | Updated: June 5th 2025

Mini Quiz: Assessment of Malingering

Mini Quiz: Methods of Suicide

Published: January 21st 2016 | Updated: June 5th 2025

Mini Quiz: Methods of Suicide

Mini Quiz: ADHD Comorbidity

Published: September 15th 2016 | Updated: June 5th 2025

Mini Quiz: ADHD Comorbidity

Mini Quiz: Psychogenic Non-Epileptic Seizures

Published: June 6th 2018 | Updated: June 5th 2025

Mini Quiz: Psychogenic Non-Epileptic Seizures

Poor DSM-5—So Misunderstood!

Published: March 23rd 2021 | Updated: June 5th 2025

Poor DSM-5—So Misunderstood!

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.